Back to DE Deerfield Management Company, L.P.

SPRYSPRY

Showing 8 of 16 quarters

Position history for DEDeerfield Management Company, L.P.'s holdings in ARS Pharmaceuticals, Inc.

Yes. Deerfield Management holds 7,503,812 shares of SPRY (ARS Pharmaceuticals), worth $32.3M, as of its Q3 2026 13F filing. The share count is unchanged from Q2 2026. Deerfield Management has held SPRY since Q4 2022, across 16 quarterly 13F filings. SPRY is 0.5% of Deerfield Management's reported 13F portfolio.

Current Value

$32.3M

Current Shares

7.5M

Total Value Change

-$78.6M

Total Shares Change

-3M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q3
Latest
Unchanged
7.5M
0.0%
$32.3M0.5%$4.31
0
2026-Q2
Unchanged
7.5M
0.0%
$60.1M0.6%$8.01
0
2026-Q1
Unchanged
7.5M
0.0%
$60.3M0.7%$8.03
0
2025-Q4
Unchanged
7.5M
0.0%
$87.4M1.1%$11.65
0
2025-Q3
Decreased
7.5M
-22.8%
$75.4M1.2%$10.05
0
2025-Q2
Decreased
9.7M
-7.5%
$169.7M3.1%$17.45
0
2025-Q1
Unchanged
10.5M
0.0%
$132.3M2.6%$12.58
0
2024-Q4
Decreased
10.5M
-5.1%
$110.9M2.1%$10.55
0

Optional analytics helps us improve. How it’s used